Literature DB >> 8782773

Severe neutropenia caused by recommended prophylactic doses of rifabutin.

G Apseloff, G Fluids, L LaBoy-Goral, E Kraut, J Vincent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8782773     DOI： 10.1016/s0140-6736(05)65109-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.

Authors:  Sander Veldhuyzen van Zanten; Snehal Desai; Linda Best; Geraldine Cooper-Lesins; Dickran Malatjalian; David Haldane; Kevork Peltekian
Journal:  Can J Gastroenterol       Date:  2010-05       Impact factor: 3.522

Review 2.  Advances in the diagnosis and treatment of tuberculosis.

Authors:  Payam Nahid; Madhukar Pai; Philip C Hopewell
Journal:  Proc Am Thorac Soc       Date:  2006

Review 3.  Rescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.

Authors:  Xiaoqun Liu; Hui Wang; Zhifa Lv; Youhua Wang; Ben Wang; Yong Xie; Xiaojiang Zhou; Nonghua Lv
Journal:  Gastroenterol Res Pract       Date:  2015-05-25       Impact factor: 2.260

4.  Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy.

Authors:  Suhashni Naiker; Cathy Connolly; Lubbe Wiesner; Tracey Kellerman; Tarylee Reddy; Anthony Harries; Helen McIlleron; Christian Lienhardt; Alexander Pym
Journal:  BMC Pharmacol Toxicol       Date:  2014-11-19       Impact factor: 2.483

5.  Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pylori.

Authors:  Hyun Chul Lim; Yong Jae Lee; Byoungrak An; Seung Woo Lee; Yong Chan Lee; Byung Soo Moon
Journal:  Helicobacter       Date:  2014-09-18       Impact factor: 5.753

Review 6.  Rifabutin for the Treatment of Helicobacter Pylori Infection: A Review.

Authors:  Javier P Gisbert
Journal:  Pathogens       Date:  2020-12-28

7.  Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Authors:  Olga P Nyssen; Dino Vaira; Ilaria Maria Saracino; Giulia Fiorini; María Caldas; Luis Bujanda; Rinaldo Pellicano; Alma Keco-Huerga; Manuel Pabón-Carrasco; Elida Oblitas Susanibar; Alfredo Di Leo; Giuseppe Losurdo; Ángeles Pérez-Aísa; Antonio Gasbarrini; Doron Boltin; Sinead Smith; Perminder Phull; Theodore Rokkas; Dominique Lamarque; Anna Cano-Català; Ignasi Puig; Francis Mégraud; Colm O'Morain; Javier P Gisbert
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.